1. No category

RxFiles - Drug Comparison Charts Book - 10th Ed.
ORDER FORM
Name (Ship to):
Address (Company Name):
Address:
City:
Postal/Zip Code:
Email optional:
Payment by: … VISA
Credit Card #:
27-Jan-15
Telephone: (
Fax optional: (
)
)
Profession: Physician…
Province/State:
Country:
… MASTERCARD
Pharmacist… Nurse Practitioner… Other…
Student…#_________ Resident… Internationally-Trained-Unlicensed…
University/College required if student: _________________Yr____
Specialty Area if any: ___________________________________
… CHEQUE or MONEY ORDER (Payable to: RxFiles c/o SCH Pharmacy)
Signature:
Credit Card Expiry:
Name of cardholder:
RxFiles Drug Comparison Charts Book – 10th Edition
Standard Size – Drug Comparison Charts
Units ordered #
All prices in
Canadian
Dollars
Total Units #
Total $
Letter-Size Book ~ 9.5” x 11 “
ISBN: 978-0-9866777-4-8
Pocket Size – Drug Comparison Charts
ISBN:
978-0-9866777-6-2
Small Book / Very Small Print ~ 5.5 “ x7.5 “
(Small print sample; some print larger & some smaller than this.)
Total Books Ordered & Cost/Unit
Standard and/or Pocket size
th
10 Edition Cover price: $85
COMBO-PACK: 1 Standard + 1 Pocket Ed.
Other
Quantity
Unit Price
1-2 units
3-6
7-14
15-44
45-149
1 of each
$85
$82
$79
$75
$70
$138 (2 Units) 1 pocket +1 standard
(a)
$120 each
or 2 for $195
(d)
Oversize RxFiles Charts Book (approx. 12” x 15”)
ISBN: 978-0-9866777-5-5
{Somewhat larger print!}
(b)
(c)
1-3 units
4-6 units
7-14 units
Bulk ≥ 15 units
Shipping & Handling (for Canada & USA only)
Payment required prior to shipping. For orders of ≥ 150 copies, contact our office.
---------------------------------------------------------
1 complimentary Book of ANY SIZE for every 60 books ordered in bulk.
add $10.00
$3 /Unit
$2 /Unit
$1 /Unit
…
…
…
…
. (e)
Amount for Shipping & Handling (S&H)
S&H
{For courier options, including international orders, please contact us for pricing & arrangements.}
Subtotal: Book(s) + Shipping & Handling
Subtotal
All Canadian Provinces & Territories add 5% GST/HST on Book(s)
(Canada Only!)
(a+b+c+d+e)
Add 5% HST/GST
Subtotal Books
(f+g)
(f)
(g)
(h)
RxFiles Online Charts Subscription – Single User:
(h)
Ö $39 /year or $69 /2 years
Online Subscription: Add GST/HST for NB, NL, NS, ON; rates shown at right.
All other Provinces (BC, AB, MB, SK, NT, PE, QC, YU) 5% GST only. (Canada Only!)
ŠMust sign-up online for RxFiles.ca User Account prior to requesting subscription:
User name: _________________________________________(or email us with username)
{Contact our office ([email protected]) for online group partnership subscriptions.}
ŠPlease allow up to 12 business days for delivery (Canada).
ŠAlso available from select university bookstores or from our online store at: www.RxFiles.ca
10th Ed Released October 2014
P.O. # if applicable: _____________________ Invoice No. __________________________
ON (13%)
NB, NL (13%)
NS (15%)
PE (14%)
All Other (5%)
Subtotal Online
(h+j)
Subscription
TOTAL DUE
(g+j)
GST Registration: 130091820RT (SHR-RxFiles)
for office use only
th
RxFiles Drug Comparison Charts – 10 Edition contains 106+ charts (11 new) and 188+ pages (22 new) cover to cover.
{New charts: e.g. bowel preparations, constipation, warfarin dosing/nomogram, opioid tapering, abnormal uterine bleeding, acute pain, migraine overview.}
ŠStandard Edition book is 9 x 11 inches, full color print, tabbed and indexed.
ŠPocket Edition 5.5” x 7” (color, tabs) is available – but has much, much smaller print. (Want both, consider the Combo-Pak!)
RxFiles Academic Detailing Program c/o Saskatoon City Hospital, 701 Queen Street, Saskatoon, SK Canada S7K 0M7
TEL: (306) 655-8505; FAX: (306) 655-7980; Email: [email protected]; Internet: www.RxFiles.ca
For more information, see our website at www.RxFiles.ca
(i)
(j)
Evidence Based Medicine (EBM)………………………………….…………i
new
CARDIOLOGY
new
5yr CVD Risk Assessment Tool………………………………….………….. 1
Antihypertensives
ACE Inhibitors & ARBs…...…..……….………...…………..……... 2
Beta Blockers…...…………………………...………………....…….. 3
Calcium Channel Blockers……..…………….……………..…….... 4
Diuretics & Misc. Antihypertensives…...….……………………... 5
Antihypertensives Summary - Guidelines & Trials..………….... 6-9
Antiplatelets & Antithrombotics.…..………………...….……………..….. 10-11
new Atrial Fibrillation………………...……………………...……...…….……… 11a-c
Heart Failure………………...……………………..……...………….…….… 12-13
Lipid Landmark Trials..……...……………………..……...……….….....… 14
Lipid Lowering Agents.……...……………………….…...………….……… 15
MI: Post Myocardial Infarction.……....……………………..………..………16
QT Prolongation & Torsades de Pointes..……....……...……………………17
DERMATOLOGY
Landmark Outcome Trials: Glycemic Control & Prevention…………30a
Lipids/ASA/BP………………………………30b
Overview & Approach to Type 2 Diabetes…………………………………30c
Obesity
Weight Loss: Drugs…………………………………………………… 31
Weight Loss: Herbal Products.……...…...………………………… 32-33
Thyroid: Hypo & Hyperthyroid Chart……………………………………34-35
new Women’s: Hirsutism, idiopathic…..……..……...…..………………………
36
GASTROINTESTINAL
Crohn’s & Ulcerative Colitis……...………...…………...…………..………37-39
GERD & Peptic Ulcer Disease: Evidence & Chart ……..……..……...… 40-41
H. pylori ……..……..……...……………….……...…..……..……..……...… 42
Irritable Bowel Syndrome.……………….……...……….………...…………43
44-45
Nausea & Vomiting Management.………...…...……….………...…………
Various OTC (see OTC GI: Dyspepsia, Constipation, Diarrhea)
GENITOURINARY
Acne Treatment…………..….……..………...…………………………..….. 18-19
Topical Corticosteroids…………..………..………...…………………...….. 20
Various OTC (see OTC Acne, Fungal, Dermatitis, Plantar Warts & Head Lice )
EENT (Eye/Ear/Nose/Throat)
Glaucoma (Topical Treatments).………..………...………….………...……21
Intranasal Corticosteroids………..……..….………...………...…………… 22
Various OTC (see OTC Congestion, Cough, Cold & Allergy )
ENDOCRINE & METABOLIC
Andropause: Testosterone Replacement…...………...…………...………23
Diabetes
Anti-hyperglycemic (Hypoglycemics)……………………………… 24-25
Glucose: Self-Monitoring Blood Glucose (SMBG) Tips……………26
Insulin Pen Delivery Devices……..………………………………… 27
Insulin Management: Chart & Clinical Tips………………………28-29
46
Erectile Dysfunction……...…………….………...……….……...……………
Sexual Dysfunction……...……………….………...…….……...……………47
Urinary Incontinence……….………………….………...……………………48-49
INFECTIOUS DISEASES
Adult Vaccines.……………………………………………….…………………50
51-53
Antifungals.……………………………..…………………………….…………
Anti-Infectives for Common Infections………………………….………… 54-55
56-57
Anti-Infectives Oral.……………………………………………….…………
new
57a-d
Hepatitis: B,C.…………………………….………………..………...…………
Human Immunodeficiency Virus (HIV)…….……………..……………… 58-59
Influenza..…….…………………………………………………..…………… 60
Malaria Prophylaxis……..………..…….…………………………………… 61
Pneumonia: Community Acquired…….......…….………………………..…62
Pneumonia: Fine Severity Risk or CURB-65 or CRB-65….……..………63
Urinary Tract Infections in Adults...………..…………………………….. 64
Disclaimer/Copyright Statement p.139
MUSCULOSKELETAL & CONNECTIVE TISSUE
Back Pain Treatment Options…………...…….………….………….......… 65
Chronic Non-Cancer Pain .…….…………….…………………………........ 66-67
Gout………………………………………………………….………………….. 68
NSAIDs & Other Analgesics (see OTC Pain Relief Chart) ………….……69
Opioids ……...……..……………….………………………………….……..... 70
new Opioids, Pain Approaches: Acute vs Palliative vs CNCP ……...……..…70a-b
Osteoporosis ………..……..………………………………………….……...... 72-73
Pediatric Pain Treatment Considerations………..…………………………71
74
Rheumatoid Arthritis: DMARDs .……..……………………..………….……
NEUROLOGY
Alzheimer’s/Dementia ……...……………………..……....…………………. 75-77
77a
Anticholinergic Drug List……..……………………..…………….…….…..…
new
Elderly/Long Term Care: Pearls for Prescribing.…………….……………77b
Essential Tremor & Restless Legs Syndrome…….….………….…………78
Multiple Sclerosis……….………….………………………..…………………79
Migraine: Acute & Prophylaxis……….………….…...………………………80-81
Parkinson’s……….………….………………………..…………………………82-83
Seizures: Antiepileptics…….………...……………..…………………………84-85
PSYCHIATRY
Attention Deficit Hyperactivity Disorder (ADHD).……………….…….. 98-99
Anxiety Disorders
Antianxiety Agents..…………….……...………….……………….…100
Benzodiazepines……...……………….……...….……………….……101
Bipolar Disorder: Mood Stabilizers………….……...…………………..... 102-3
Depression
Antidepressants……...……………….……...…….……………….… 104-5
Antidepressant Drug Interactions….…….……………….……...…106
Hypersexuality Treatment Options………….……....……...………....... 107
Schizophrenia: Antipsychotics..……………….…...……………………… 108-9
Sleep Disorders: Sedatives.……………….……...………………….......... 110-11
new
OBSTETRICS & GYNECOLOGY
Contraception
86-87
Oral Contraceptive …….……....……………..……………………..…
88
Other Hormonal Birth Control ………..…………………..…………
Menopause
Postmenopausal Herbal Therapy………………….……...…………89
Postmenopausal Drug Therapy………..………………….……...…90
new
Peri-Pregnancy Drug Considerations…………….……...……………… 91a-b
OVER THE COUNTER (OTC) & HERBAL MEDICATIONS
Cold-fX, Glucosamine & Lakota Herbal Products………….....……………91
OTC Herbal Drug Interactions……...………………………………………………92-93
Congestion; Cough; Cold; Allergy…………………………………….…….. 94
GI: Dyspepsia, Constipation & Diarrhea; Pain relief……………………. 95
Acne; Fungal; Dermatitis……………………………………………….……. 96
Plantar Warts; Head Lice & Vitamins……………...…………………...… 97
Disclaimer/Copyright Statement p.139
RESPIRATORY
Asthma & COPD
Pharmacotherapy…..……..……...……………….……...……………112-13
Inhalational Devices.……………….……...……………………....... 114
SMOKING CESSATION
Smoking Cessation Chart…….……………….……...…………………….. 115
MISCELLANEOUS
Cannabinoids: Overview.……………….……...………….………...…....... 116
Canadian Health Agencies & Regulatory Environment.……...…......... 117
CKD Anemia Landmark Trials…….…….………….……...…………..…………118-19
120
Erythropoetin Comparison…….……...……………….……...………………
Iron Replacement…….……...………………………….……...……………. 121
Phosphate Binder…….……...………………………….……...……………. 121a-b
new
Palliative Care………….………………..…...…………………..…….......... 121c-d
Patient Safety: Medication Issues…...…………………..…..................... 122
RxFiles Program, Academic Detailing Overview……..…...................... 123
Substance Abuse Chart……….………..…...…………………..…............. 124-5
Transplantation Chart…………..…...…………………..…....................... 126-7
INDICES
Newsletters & Q&A’s…………..…...…...……………..….......................... 128
Drug, Disease & Trial…………..…...…...……………..…......................... 129-38
Abbreviations & Symbols…………..….....………………..….................... 139